Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McMaster University

$105,000.00

Dietary triggers of gastrointestinal symptoms in patients with irritable bowel syndrome

EF 2020-21

Résumé
Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits. It affects over 5 million Canadians, producing an economic burden of over $6.5 billion per year. Gluten is the protein found in wheat, rye, and barley responsible for the elastic properties and texture of flour. It is commonly believed to trigger IBS symptoms; however, the mechanism is not yet understood. Also found in wheat, rye, and barley, amylase trypsin inhibitors (ATIs) may contribute to IBS symptoms by activating the innate immune system. ATIs are present in higher quantities in modern wheat, which may explain the greater reported levels of gluten and wheat sensitivity than in the past. Current research suggests that ATIs and gluten interact to trigger more severe symptoms. However, there are no studies in IBS patients investigating the effects of pure gluten versus gluten with ATIs. We designed a placebo-controlled study to investigate the effects of pure gluten compared to gluten with ATIs. IBS patients (n=35) whose symptoms improve on a gluten-free diet will be randomly assigned to consume granola bars containing either pure gluten, gluten with ATIs, or placebo (gluten-free flour). Participants will receive the three different interventions in a period of 10 weeks separated by 2-week washout periods. We will study the underlying mechanisms, including the effects on the immune system and gut bacteria. This research is the first to test the effects of pure gluten against gluten with ATIs in IBS patients. If some patients are sensitive to ATIs instead of gluten, this research would allow for the development of ATI-free foods using pure gluten so that ATI-sensitive individuals can consume gluten-containing breads, pastas, and pastries. The results will also improve our understanding of the potential mechanisms and effects of gluten and ATIs on IBS, leading to better diagnosis and personalized dietary recommendations in the future.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
439611
Name
Seiler Caroline
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Dietary triggers of gastrointestinal symptoms in patients with irritable bowel syndrome
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Amylase Trypsin Inhibitors; Clinical Trial; Crossover; Gastrointestinal Symptoms; Gluten; Gluten-Free Diet; Irritable Bowel Syndrome
Abstract
Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits. It affects over 5 million Canadians, producing an economic burden of over $6.5 billion per year. Gluten is the protein found in wheat, rye, and barley responsible for the elastic properties and texture of flour. It is commonly believed to trigger IBS symptoms; however, the mechanism is not yet understood. Also found in wheat, rye, and barley, amylase trypsin inhibitors (ATIs) may contribute to IBS symptoms by activating the innate immune system. ATIs are present in higher quantities in modern wheat, which may explain the greater reported levels of gluten and wheat sensitivity than in the past. Current research suggests that ATIs and gluten interact to trigger more severe symptoms. However, there are no studies in IBS patients investigating the effects of pure gluten versus gluten with ATIs. We designed a placebo-controlled study to investigate the effects of pure gluten compared to gluten with ATIs. IBS patients (n=35) whose symptoms improve on a gluten-free diet will be randomly assigned to consume granola bars containing either pure gluten, gluten with ATIs, or placebo (gluten-free flour). Participants will receive the three different interventions in a period of 10 weeks separated by 2-week washout periods. We will study the underlying mechanisms, including the effects on the immune system and gut bacteria. This research is the first to test the effects of pure gluten against gluten with ATIs in IBS patients. If some patients are sensitive to ATIs instead of gluten, this research would allow for the development of ATI-free foods using pure gluten so that ATI-sensitive individuals can consume gluten-containing breads, pastas, and pastries. The results will also improve our understanding of the potential mechanisms and effects of gluten and ATIs on IBS, leading to better diagnosis and personalized dietary recommendations in the future.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Seiler, Caroline
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~